TruMed Systems secures $5.5M in Series B funding

TruMed Systems

TruMed Systems has graduated from EvoNexus incubator with $5.5 million in Series B funding. This additional financing will enable the company to expand its product offering and rely on San Diego based firm D&K Engineering for production.

TruMed makes the turnkey Vaccine Management Solution AccuVax, which is focused on vaccine storage and delivery and will provide physician offices a turnkey solution that is unlike anything else available in the market. It entered the EvoNexus program in April 2013 and utilized the various benefits the program provides including office space, mentorship, potential customers and partners and access to educational start up focused programming.

While part of the incubator, TruMed completed a $3.2M Series A funding round in 2013. The company will be moving into an Irvine Company office space in the UTC area.